personalized, responsive service and to improve the site, we remember and store information about how you use
Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
Welcome to the August issue where, in our cover feature, we dive into the “outsourcing dilemma:” should you opt for a one-stop shop or specialist supply chain? Upfront examines current trends in US drug pricing and the potential of the innate immune system in the fight against cancer. Steve Arlington makes the case for maintaining links across borders, in In My View; while Best Practice outlines the steps to successfully bringing an advanced medicine to market. NextGen is skeptical about blockchain and dives into the story behind the UK’s CPI. And finally, we Sit Down With Adrian Woolfson, Vice President of Research and Development, Sangamo Therapeutics.